The findings demonstrated that PRAD and UVM tumor immune cell infiltration were positively connected with RBP1, and OV, HNSC, and BRCA tumor immune cell infiltration significantly negatively correlated with RBP1. According to this analysis, RBP1 may impact the tumor's immune microenvironment and the course of cancer. Here, RBP1 is linked to invasive breast carcinoma.